News for Healthier Living

Houston Methodist Develops First Personalized mRNA Cancer Vaccine for Osteosarcoma

In a breakthrough poised to reshape cancer treatment, Houston Methodist has developed the first personalized mRNA cancer vaccine designed to prevent recurrence of osteosarcoma, a rare and aggressive type of bone cancer.

May 13, 2026


May 16 2026

May 15 2026

May 14 2026

May 13 2026

May 12 2026

May 11 2026

May 10 2026

May 8 2026

May 7 2026

May 6 2026

May 5 2026

May 4 2026